Skip to content

Point-of-Care Bedside Lung Ultrasound Examination Advanced Trial Protocol

A Prospective, Multi-center, Open-label and Double-blind, Standard-controlled, Non-inferiority, Diagnostic Study of Lung Ultrasound for Management of Mechanical Ventilation in Neonatal Acute Respiratory Distress Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02403791
Acronym
PoCBLUEPlus
Enrollment
1000
Registered
2015-03-31
Start date
2014-03-31
Completion date
2015-03-31
Last updated
2015-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Keywords

Acute Respiratory Distress Syndrome

Brief summary

The purpose of this study was to evaluate the availability and diagnostic accuracy of point-of-care bedside lung ultrasound examination in management of mechanical ventilation in neonatal acute respiratory distress syndrome.

Detailed description

Neonatal acute respiratory distress syndrome (ARDS) is a critical condition requiring dynamic evaluation and interventions. Point-of-care bedside lung ultrasound examination (PoC-BLUE) is a noninvasive, readily available imaging modality that can complement physical and clinical evaluation. At any time, most neonates and infants with ARDS in medical intensive care units (ICUs) require mechanical ventilation, making it one of the most frequently used critical care technologies. However, difficulties with regard to the accurate diagnosis of ARDS before administration of mechanical ventilation, dynamic monitoring of treatment effects during administration of mechanical ventilation, and decision-making of timing in weaning from mechanical ventilation, are often encountered in the majority neonates and infants who require mechanical ventilation. Hence, techniques that expedite and advance the knowledge of the administration of mechanical ventilation should have an important clinical significance in the diagnosis, treatment and prognosis of ARDS. Preliminary researches have suggested that BLUE has a high diagnostic accuracy in patients with acute respiratory failure, and has the potential to quantify the rate and degree of diaphragm thinning during mechanical ventilation, which may be useful to predict extubation success or failure during either spontaneous breathing (SB) or pressure support (PS) trials. Unfortunately, few studies focus on the availability of PoC-BLUE in management of mechanical ventilation in neonatal acute respiratory distress syndrome. Also, they call into question the possible association of the demographic and clinical confounders with the diagnostic accuracy of PoC-BLUE for diagnosis, monitoring and prognosis of ARDS in the whole process of mechanical ventilation. Given that a considerable need for a timely and dynamic diagnosis of severe condition and therapy evaluation during mechanical ventilation has been triggered to integrate the currently available bulk of knowledge and information, the objective of this study is to investigate the availability and diagnostic accuracy of PoC-BLUE Plus protocol in management of mechanical ventilation in ARDS.

Interventions

DEVICELinear Ultrasonic Sounder

Lung ultrasound evaluation is performed after clinical assessment and before chest radiography

DEVICEBedside X-ray Machine

Chest Radiography is performed after clinical evaluation without using ultrasound assessment.

Sponsors

The second affiliated hospital of Jinan University School of Medicine
CollaboratorUNKNOWN
First Affiliated Hospital of Chengdu Medical College
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Women and Children Health Hospital of Jiangsu Province
CollaboratorUNKNOWN
Affiliated Hospital of Sichuan Vocational College of Health and Rehabilitation
CollaboratorUNKNOWN
First Affiliated Hospital of Jinan University
CollaboratorOTHER
Yangzhou University
CollaboratorOTHER
The Third Affiliated Hospital of Southern Medical University
CollaboratorOTHER_GOV
The Sichuan Second Hospital of Guangxi Medical University
CollaboratorUNKNOWN
Guangzhou General Hospital
CollaboratorOTHER
Nankai University School of Medicine
CollaboratorOTHER
Guangdong Medical College
CollaboratorOTHER
Chongqing Medical University
CollaboratorOTHER
Tsinghua University
CollaboratorOTHER
Guiyang Medical University
CollaboratorOTHER
Shenzhen Institutes of Advanced Technology Chinese Academy of Science
CollaboratorUNKNOWN
Jiamusi University
CollaboratorUNKNOWN
The University of Science and Technology of China
CollaboratorOTHER
Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 31 Days
Healthy volunteers
No

Inclusion criteria

* All infants who present to the ICU with respiratory symptoms suspicious for ARDS, according to Pediatric Acute Respiratory Distress Syndrome: Consensus Recommendations From the Pediatric Acute Lung Injury Consensus Conference, which is proposed by The Pediatric Acute Lung Injury Consensus Conference Group. * In whom the treating Collaborative Review Groups of Poc-BLUE-Plus protocol believe would benefit from diagnostic imaging.

Exclusion criteria

* Infants who arrive at the ICU with a previously performed chest radiography * Unstable infants with life-threatening injuries who require ongoing resuscitation

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Lung Ultrasound in Neonatal ARDSAccuracy will be measured at the end of clinical evaluation in the ICU, an expected average of 4 daysAccuracy of lung ultrasound and chest radiography will be measured using as gold standard the independent evaluation of the entire medical records by two expert emergency physicians blinded to the lung ultrasound results and radiographic reports (digitalized chest radiography images will be available).

Secondary

MeasureTime frameDescription
Accuracy of Lung Ultrasound in the Ventilator-Associated PneumoniaAccuracy will be measured at the end of clinical evaluation in the ICU, an expected average of 4 daysAccuracy of lung ultrasound and chest radiography will be measured using as gold standard the independent evaluation of the entire medical records by two expert emergency physicians blinded to the lung ultrasound results and radiographic reports (digitalized chest radiography images will be available).
Accuracy of Lung Ultrasound in the Weaning of Ventilatory SupportAccuracy will be measured at the end of clinical evaluation in the ICU, an expected average of 4 daysAccuracy of lung ultrasound and chest radiography will be measured using as gold standard the independent evaluation of the entire medical records by two expert emergency physicians blinded to the lung ultrasound results and radiographic reports (digitalized chest radiography images will be available).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026